These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 36176311)
1. Lactobacilli metabolites restore E-cadherin and suppress MMP9 in cervical cancer cells. Pawar K; Aranha C Curr Res Toxicol; 2022; 3():100088. PubMed ID: 36176311 [TBL] [Abstract][Full Text] [Related]
2. Normal and tumour cervical cells respond differently to vaginal lactobacilli, independent of pH and lactate. Motevaseli E; Shirzad M; Akrami SM; Mousavi AS; Mirsalehian A; Modarressi MH J Med Microbiol; 2013 Jul; 62(Pt 7):1065-1072. PubMed ID: 23618799 [TBL] [Abstract][Full Text] [Related]
3. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines. Liu Y; Liu L; Mou ZX Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331 [TBL] [Abstract][Full Text] [Related]
4. Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. McLEAN NW; Rosenstein IJ J Med Microbiol; 2000 Jun; 49(6):543-552. PubMed ID: 10847208 [TBL] [Abstract][Full Text] [Related]
5. Reciprocal interference between Lactobacillus spp. and Gardnerella vaginalis on initial adherence to epithelial cells. Castro J; Henriques A; Machado A; Henriques M; Jefferson KK; Cerca N Int J Med Sci; 2013; 10(9):1193-8. PubMed ID: 23935396 [TBL] [Abstract][Full Text] [Related]
6. In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women. Matu MN; Orinda GO; Njagi EN; Cohen CR; Bukusi EA Anaerobe; 2010 Jun; 16(3):210-5. PubMed ID: 19925874 [TBL] [Abstract][Full Text] [Related]
7. Lactobacilli inhibit cervical cancer cell migration in vitro and reduce tumor burden in vivo through upregulation of E-cadherin. Li X; Wang H; Du X; Yu W; Jiang J; Geng Y; Guo X; Fan X; Ma C Oncol Rep; 2017 Sep; 38(3):1561-1568. PubMed ID: 28713905 [TBL] [Abstract][Full Text] [Related]
8. Exploring of probiotic potential vaginal lactobacillus isolates from healthy women against Gardnerella vaginalis and Caenorhabditis elegans model testing. Li Y; Jiang Y; Lessing DJ; Chu W J Appl Microbiol; 2022 Sep; 133(3):1392-1401. PubMed ID: 35633296 [TBL] [Abstract][Full Text] [Related]
9. The Effect of Lactobacillus crispatus and Lactobacillus rhamnosusCulture Supernatants on Expression of Autophagy Genes and HPV E6 and E7 Oncogenes in The HeLa Cell Line. Motevaseli E; Azam R; Akrami SM; Mazlomy M; Saffari M; Modarressi MH; Daneshvar M; Ghafouri-Fard S Cell J; 2016; 17(4):601-7. PubMed ID: 26862519 [TBL] [Abstract][Full Text] [Related]
10. Dual Anti-Metastatic and Anti-Proliferative Activity Assessment of Two Probiotics on HeLa and HT-29 Cell Lines. Nouri Z; Karami F; Neyazi N; Modarressi MH; Karimi R; Khorramizadeh MR; Taheri B; Motevaseli E Cell J; 2016; 18(2):127-34. PubMed ID: 27551673 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens. Scillato M; Spitale A; Mongelli G; Privitera GF; Mangano K; Cianci A; Stefani S; Santagati M Microbiologyopen; 2021 Feb; 10(2):e1173. PubMed ID: 33970542 [TBL] [Abstract][Full Text] [Related]
12. Hydrogen Peroxide-Producing Lactobacilli Are Associated With Lower Levels of Vaginal Interleukin-1β, Independent of Bacterial Vaginosis. Mitchell C; Fredricks D; Agnew K; Hitti J Sex Transm Dis; 2015 Jul; 42(7):358-63. PubMed ID: 26222747 [TBL] [Abstract][Full Text] [Related]
13. Parolin C; Frisco G; Foschi C; Giordani B; Salvo M; Vitali B; Marangoni A; Calonghi N Front Microbiol; 2018; 9():2630. PubMed ID: 30459737 [TBL] [Abstract][Full Text] [Related]
14. das Neves Selis N; de Oliveira HBM; Dos Anjos YB; Leão HF; Sampaio BA; Correia TML; Reis MM; Brito TLS; Almeida CF; Pena LSC; Brito LF; Ornelas RM; Santos TT; Campos GB; Timenetsky J; Cruz MP; da Costa AM; Yatsuda R; Uetanabaro APT; Marques LM Biomed Res Int; 2021; 2021():6626249. PubMed ID: 33997030 [TBL] [Abstract][Full Text] [Related]
15. Selection of Lactobacillus strains as potential probiotics for vaginitis treatment. Santos CMA; Pires MCV; Leão TL; Hernández ZP; Rodriguez ML; Martins AKS; Miranda LS; Martins FS; Nicoli JR Microbiology (Reading); 2016 Jul; 162(7):1195-1207. PubMed ID: 27154285 [TBL] [Abstract][Full Text] [Related]
16. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review. Barrons R; Tassone D Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterisation of vaginal lactobacilli from South African women. Pendharkar S; Magopane T; Larsson PG; de Bruyn G; Gray GE; Hammarström L; Marcotte H BMC Infect Dis; 2013 Jan; 13():43. PubMed ID: 23351177 [TBL] [Abstract][Full Text] [Related]
18. In-vitro effect of vaginal lactobacilli against group B Streptococcus. Marziali G; Foschi C; Parolin C; Vitali B; Marangoni A Microb Pathog; 2019 Nov; 136():103692. PubMed ID: 31445119 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of vaginal lactobacilli by a bacteriocin-like inhibitor produced by Enterococcus faecium 62-6: potential significance for bacterial vaginosis. Kelly MC; Mequio MJ; Pybus V Infect Dis Obstet Gynecol; 2003; 11(3):147-56. PubMed ID: 15022875 [TBL] [Abstract][Full Text] [Related]